Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Alberto E. Musto

Alberto E. Musto

Eastern Virginia Medical Schoool, USA

Fangyu Peng

Fangyu Peng

USA

Ana Patricia Aguilera Hermida

Ana Patricia Aguilera Hermida

Penn State University, USA

Ornit Chiba-Falek

Ornit Chiba-Falek

Duke University Medical Center, USA

Lucio Parmeggiani

Lucio Parmeggiani

Bozen Regional Hospital, Italy

Thomas Dorn

Thomas Dorn

Swiss Epilepsy Center, Switzerland

Paula Kielbik

Paula Kielbik

Warsaw University of Life Sciences, Poland

Matthias L Schroeter

Matthias L Schroeter

Max Planck Institute for Human Cognitive and Brain Sciences , Germany

Euro Dementia 2019

About Conference


Euro Dementia 2019 organizing committee are esteemed to invite in upcoming "12th World Congress on Dementia and Alzheimer Rehabilitation’’ scheduled during April 11-12, 2019 in Stockholm, Sweden. With honour we welcome you to join the congress which is mainly based on the theme ‘’Different innovative approaches to treat mental disorder diseases specially Dementia & Alzheimer’s disease and their rehabilitation’’.

European conferences anticipates more than 500 participants around the globe to experience thought provoking keynote lectures, oral & poster presentations. This year conference will offer ample opportunities for all stakeholders working on Dementia, Alzheimer’s and neurologic disorder to expose their research work.

Dementia 2019 is organizing an outstanding scientific exhibition/program and anticipates the world's leading neurologists, health professionals involved in the profession and practice of neuroscience. The neurological disorder event will also reflect interest of specialists in the clinical research on Dementia rehabilitation. This dementia congress  is for people to take part and gain a better understanding of such diseases, to access treatment as well as information and advice. This is an effort to make possible interactions among world leading scientists, research scholars, professionals, young researchers, principal investigators, experts and researchers working on brain from both academia and health care industry, business delegates, scientists and students from different parts of the world to exchange their knowledge and conduct dementia symposia, show experiments with new innovative techniques that disseminate information about clinical tradition, best practices, skills and knowledge in the field of neuroscience.This event will provide an international forum for the dissemination of original research results, new ideas and practical development experiences all over the globe.

In Dementia and Alzheimer’s rehabilitation 2019 conference, international symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of psychiatric disorder and mental health.

Within this splendid setting, we plan to deliver a conference that will exceed your expectations. Our event aims to makesociety dementia feel safe and to create a familiar environment for them.

During this year’s conference, we hope that you will seize the opportunity to rekindle on-going connections and spark new ones with your colleagues from around the globe.

 

 

Important Dates

                              Submit Abstract: URL

Abstract Submission:

  • 1st Deadline: December 29, 2018
  • 2nd Deadline: February 10, 2019
  • 3rd Deadline: February 25, 2019
  • Final Call: April 11-12, 2019

                            Register now: URL

Registration:

  • 1st Early Bird: January 24, 2019
  • 2nd Early Bird: February 20, 2019
  • 3rd Early Bird: March 05, 2019
  • Final Call: April 11-12, 2019

Sessions/Tracks

Dementia Rehabilitation describes a set of symptoms include memory loss and difficulties with thinking or reasoning that reduce a person ability to perform everyday activities. Dementia is mainly caused when the brain is damaged by diseases, such as Alzheimer’s disease or a series of strokes. This disease mainly affects people over the age of 65 and the likelihood of developing dementia increases significantly with age. However, dementia can affect younger people too.

Conference scientific Tracks:

Track 1: Dementia

Dementia is not a specific disease. It's an overall term that describes a wide range of symptoms associated with a decline in memory or other thinking skills severe enough to reduce a person's ability to perform everyday activities. Alzheimer's disease. Vascular dementia, which occurs after a stroke, is the second most common dementia type. 

 1:Dementia with Lewy Bodies

 2:Mixed dementia.

 3:Frontotemporal dementia.

 4:Normal pressure hydrocephalus

 5:Signs and symptoms of dementia

Track 2: Alzheimer’s Disease

Alzheimer's is the most common form of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. Alzheimer's disease accounts for 60 to 80 percent of dementia cases. Alzheimer's is the most common form of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. Alzheimer's disease accounts for 60 to 80 percent of dementia cases. Alzheimer's is not a normal part of aging. 

 1:Risk Factors of alzheimers

 2:Diagnosis of alzheimers

 3:Treatments of alzheimers

 4:Clinical Studies of alzheimers

 5:Alzheimer’s disease Pathophysiology and Disease Mechanisms

Track 3: Dementia  and Ageing

Aging: Not being able to remember details of a conversation or event that took place a year ago, Not being able to remember the name of an acquaintance, Forgetting things and events occasionally, Occasionally have difficulty finding words, You are worried about your memory but your relatives are not..

Dementia: Not being able to recall details of recent events or conversations, Not recognizing or knowing the names of family members, Forgetting things or events more frequently, Frequent pauses and substitutions when finding words, Your relatives are worried about your memory, but you are not aware of any problems   

 1:Neuro-anatomical changes in ageing

 2:Risk factors of cognitive decline

 3:Granulovacuolar degeneration

 4:Changes in cerebral cortical microvasculature

 5:Advances of research in ageing and dementia

Track 4: Vascular Dementia

Vascular dementia occurs when vessels that supply blood to the brain become blocked or narrowed. Strokes take place when the supply of blood carrying oxygen to the brain is suddenly cut off. However, not all people with stroke will develop vascular dementia.

 1:Vascular dementia prognosis

 2:Young onset dementia

 3:Multi-infarct dementia

 4:Mixed dementia

 5:Parkinson dementia

 6:Advences in vascular dementia therapy

Track 5: Geriatrics Dementia and Cognitive Disorders

Geriatrics or geriatric medication may be a specialty that focuses on health care of older people. It aims to push health by preventing and treating diseases and disabilities in older adults. there's no set age at that patients are also underneath the care of a specialist or geriatric .

 1:Delirium

 2:Mild and Major Neurocognitive Disorder

Track 6: Animal Models in Dementia

The animal models of dementia  and Alzheimer's disease for pre-clinical testing and clinical translation. Dementia is a clinical syndrome with abnormal degree of memory loss and impaired ability to recall events from the past often characterized by Alzheimer's disease.

 1:Neurobehavioral Toxicology Testing

 2:pre-clinical testing and clinical translation

 3:Protein-protein interactions

 4:Genetics of translational models

 5:Animal models of human cognitive aging

Track 7: Amyloid Protein in Alzheimer’s and Dementia

Alzheimer's disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the β-amyloid peptide (Aβ) within the brain along with hyperphosphorylated and cleaved forms of the microtubule-associated protein tau.

1:Amyloid Imaging

2:FDG-PET

3:Amyloid Immunotherapy

Track 8: Dementia Care Management

The developing number of vascular dementia patients prompts both approach, monetary and wellbeing association imperatives. Numerous social insurance frameworks have created case administration programs with a specific end goal to advance dementia patients and guardians care and administrations conveyance.

 1:Advances in dementia care management

 2:Dementia care management program

 3:Undernutrition and obesity in dementia

 4:Advance care planning

Track 9: Dementia Nursing

People with vascular dementia have different mental element shortfalls that incorporate every memory hindrance, that influences the adaptability to discover new data or review data already learned, and one or extra of the ensuing side effects apraxia, agnosia, or official brokenness to such an extent that the mental element shortages adversely affect social or action working with a major decrease in past abilities.

 1:Dementia nursing care plan

 2:Music therapy in dementia

 3: Dementia Physiotherapy

 4:Clinical features of dementia

 5: Dementia Therapeutic intervention

Track 10: Recent Advancement in Treating Dementia

Early discovery and exact analysis are critical, as vascular dementia is at any rate halfway preventable. Ischemic changes in the cerebrum are irreversible, however the patient with vascular dementia can exhibit times of solidness or even gentle change. Since stroke is a basic piece of vascular dementia, the objective is to forestall new strokes. This is endeavored through decrease of stroke chance components, for example, hypertension, high blood lipid levels, atrial fibrillation, or diabetes mellitus. 

 1:Primary mental health care and nursing

 2:Psychopharmacological treatment

 3:Advanced drugs for dementia

 4:Cognitive behavioral therapy

 5:Family therapy in nursing

 

Target Audience & Benefits

Target Audience:

  • Neurologists
  • Psychiatrist
  • Neurosurgeons
  • Psychologist
  • Neuroscientists
  • Brain Specialists
  • Researchers
  • Neuro Physiotherapists
  • Lecturers and Students from Academia in the study of dementia and Alzheimer disease
  • Lecturers and Understudies from the scholarly world in the investigation of Dementia
  • Health mind experts
  • Mental disorder specialists
  • Physicians Assistants
  • Special Educators
  • Health care professionals
  • Doctors, Nurses
  • Physician Assistants
  • Occupational Therapists
  • Parents, Family Members, Caregivers, Advocates
  • General Educators
  • Special Educators
  • Education consultants
  • Employment services
  • Transition to work and post school providers
  • Paraprofessionals
  • Policy makers (government and non-government)
  • Pupil Service Directors
  • Superintendents
  • Professors
  • Industrial Experts
  • Nutritional Scientists

Benefits:

  • Access to all Sessions
  • CPD Certification
  • Abstracts will be published with unique DOI number
  • Certificate Accreditation by the International Organizing Committee
  • Handbook & Conference Kit
  • Abstracts will be published in the conference souvenir and respective international journals
  • Ask the Expert Forums (One to One Pre-Scheduled meeting on interest and availability)
  • Access to the attendees email list (post conference)
  • 25% abatement on the registration fees for the next annual conference

 

Visa Application

For conference attendance and participation only Business Visa should be applied. Contact your nearest travel agent/visa information center/ Sweden Embassy for the correct application form.

All visas for visiting / Sweden shall be processed by respective authorities only upon submission of proper documents through proper channel.

In case of non-furnishing of documents, non-adherence to guidelines visas shall be cancelled by respective authorities.

The minimum supportive documents that might be required while applying for / Sweden visa include:

Letter of invitation,

Abstract acceptance letter (if speaker),

Registration payment receipt,

Accommodation confirmation letter issued under conference letter head.

For letter of invitation and accommodation confirmation, payment of registration fees and accommodation charges is a pre-requisite.

Mandate documents required from conference secretariat should be obtained only through Edward Parker

For more details please contact:

Edward Parker

Program Manager

Euro Dementia Meetings 2019

E:  dementia@europemeet.com

E: dementia2019meetings@gmail.com

Past Conference Report

Dementia 2017

‘’9th International Conference on Dementia and Alzheimer's rehabilitation’’ was organized during October 16-18, 2017 at the venue The Holiday Inn Aurelia in Rome, Italy. With the support and contribution of the Organizing Committee members, we successfully hosted the event at the conference venue.

Firstly we must thank you for trusting us and participating Dementia 2017, a global platform to discuss various important aspects of neurological disorders and mental disorders.

There are infinite reasons to extend our gratitude to you for making the conference outstanding one. We couldn't have done it without your continuous support and believe towards our organization, which mutually made to achieve Alzheimer’s rehabilitation congress 2017 a new heights in the field of mental health.

The conference was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 30 countries, who have driven this event into the path of success. 

The conference was organized around the theme “An Insight into Advanced Research and Diagnostic Approaches in Alzheimer’s Disease and Dementia. The event implanted a firm relation of upcoming strategies in the field of Autism with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The conference witnessed an amalgamation of peerless speakers, keynote speakers, well-known researchers and delegates who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of dementia and Alzheimer’s disease through their fabulous presentations at the podium of Dementia 2017


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date April 11-12, 2019

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Day 1

Past Conference Report

Supported By

Journal of Alzheimers Disease & Parkinsonism Journal of Neurological Disorders Brain Disorders & Therapy

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner